
Equillium Announces Up to $50 Million Financing to Advance EQ504, a Novel Aryl Hydrocarbon Receptor Modulator, into the Clinic
August 11, 2025
August 11, 2025
August 11, 2025
August 7, 2025
August 7, 2025
August 7, 2025
August 4, 2025
July 29, 2025
July 29, 2025
July 28, 2025
July 24, 2025
July 24, 2025
July 22, 2025
July 21, 2025
July 21, 2025
July 16, 2025
July 16, 2025